Also listed on Inozyme Pharma, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Apr 27, 2026 (Citibank, N.A.).
Term ends Apr 28, 2043 · Medium confidence
20-year base term ends Jun 8, 2041
Why Medium: A parent in the chain could not be resolved.
Held by Biomarin Pharmaceutical Inc.
Filed Dec 8, 2022 as application 18/063,263 · Granted Aug 4, 2026
Base term plus 689 days of patent term adjustment (USPTO delay)
Today
2021
2043
Clock starts
Jun 8, 2021
Jun 8, 2021
Term ends
Apr 28, 2043
Apr 28, 2043
Granted
Aug 4, 2026
Aug 4, 2026
base term
patent term adjustment
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
689
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 689 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 8, 2021, when application PCT/US2021/036494, the earliest non-provisional in its chain, was filed (this one was filed Dec 8, 2022); a parent in its chain could not be resolved (the next row) | Jun 8, 2041 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +689 days, USPTO patent term adjustment record | Apr 28, 2043 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 28, 2043 | Medium confidence |
This family
| Application PCT/US2021/036494 | PCT application no patent term | no patent term |
| US 12,698,487 | this patent Apr 2043 | Apr 2043 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 4, 2024 Reel 67009, frame 515 | Cheng, Zhiliang; Jungles, Steven | Inozyme Pharma, Inc. | Assignment of Assignor's Interest |
| Apr 4, 2024 Reel 67009, frame 554 | Braddock, Demetrios; Stabach, Paul | Yale University | Assignment of Assignor's Interest |
| Nov 25, 2025 Reel 73707, frame 488 | Inozyme Pharma, Inc. | Biomarin Pharmaceutical Inc. | Assignment of Assignor's Interest |
| Apr 27, 2026 Reel 75493, frame 968 | Biomarin Pharmaceutical Inc.; Amicus Therapeutics, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2043
Term ends Apr 28, 2043. Maintenance fees still fall due before then
Note
The 689 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
We have no citation count for this patent yet. That is not the same as never having been cited.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.